A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Goldsmith, D R, Rapaport, M H, Miller, B J·2016·Molecular Psychiatry

Cited by (1,002)

Items 701–800 of 1,002

  1. Association Between Inflammatory Cytokines, Executive Function, and Substance Use in Patients With Opioid Use Disorder and Amphetamine-Type Stimulants Use Disorder
    Tzu‐Yun Wang, Ru‐Band Lu, Sheng-Yu Lee, Yun-Hsuan Chang, Shiou‐Lan Chen, Tsung-Yu Tsai, Huai‐Hsuan Tseng, Po See Chen, Kao Chin Chen, Yen Kuang Yang et al. · 2022 · The International Journal of Neuropsychopharmacology
  2. Linking nervous and immune systems in psychiatric illness: A meta-analysis of the kynurenine pathway
    Paulo Marcelo Gondim Sales, Ezra Schrage, Richard Coico, Michele T. Pato · 2022 · Brain Research
  3. Liposaccharide-induced sustained mild inflammation fragments social behavior and alters basolateral amygdala activity
    Maxine K. Loh, Courtney P. Stickling, Sean Schrank, Madison Hanshaw, Alexandra C. Ritger, Naijila Dilosa, Joshua Finlay, Nicole C. Ferrara, J. Amiel Rosenkranz · 2023 · Psychopharmacology
  4. Association of severe mental illness and septic shock case fatality rate in patients admitted to the intensive care unit: A national population-based cohort study
    Inès Lakbar, Marc Léone, Vanessa Pauly, Veronica Orléans, Kossi Josué Srougbo, Sambou Diao, Pierre‐Michel Llorca, Marco Solmi, Christoph Ulrich Correll, Sara Fernandes et al. · 2023 · PLoS Medicine
  5. Correlation between elevated serum interleukin-1β, interleukin-16 levels and psychiatric symptoms in patients with schizophrenia at different stages
    Xialong Cheng, Yu Xie, Anzhen Wang, Cuizhen Zhu, Fanfan Yan, Wenzhi Pei, Xulai Zhang · 2023 · BMC Psychiatry
  6. Prevalence of sleep disturbance in patients with ankylosing spondylitis: a systematic review and meta-analysis
    Nader Salari, Narges Sadeghi, Amin Hosseinian Far, Razie Hasheminezhad, Habibolah Khazaie, Shamarina Shohaimi, Masoud Mohammadi · 2023 · Revista Brasileira de Reumatologia
  7. The immunomodulatory effect of lithium as a mechanism of action in bipolar disorder
    Łukasz Piotr Szałach, Katarzyna Aleksandra Lisowska, Wiesław Jerzy Cubała, Margherita Barbuti, Giulio Perugi · 2023 · Frontiers in Neuroscience
  8. Breaking free from the inflammatory trap of depression: Regulating the interplay between immune activation and plasticity to foster mental health
    Igor Branchi, Aurelia Viglione, Benedetta Vai, Francesca Cirulli, Francesco Benedetti, Silvia Poggini · 2023 · Neuroscience Applied
  9. Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study
    Mst. Sarmin Akter, Faisal Abdullah Emon, Zabun Nahar, MMA Shalahuddin Qusar, Sardar Mohammad Ashraful Islam, Mohammad Shahriar, Mohiuddin Ahmed Bhuiyan, Md. Rabiul Islam · 2023 · BMC Psychiatry
  10. The Role of Inflammation in Depression and Beyond: A Primer for Clinicians
    Eduardo Andres Calagua-Bedoya, Vignesh Rajasekaran, Lot D. de Witte, M. Mercedes Pérez-Rodríguez · 2024 · Current Psychiatry Reports
  11. Monoclonal antibody immunotherapy in psychiatric disorders
    Brian J. Miller, P.F. Buckley · 2016 · The Lancet Psychiatry
  12. Diet and Neurocognition in Mood Disorders - An Overview of the Overlooked
    Vicent Balanzá‐Martínez, Flávio Shansis, Amparo Tatay-Manteiga, Pilar López-García · 2020 · Current Pharmaceutical Design
  13. Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial
    Sheng-Yu Lee, Tzu‐Yun Wang, Shiou‐Lan Chen, Yun‐Hsuan Chang, Po See Chen, San‐Yuan Huang, Nian‐Sheng Tzeng, Liang‐Jen Wang, I‐Hui Lee, Kao-Ching Chen et al. · 2020 · International Journal of Bipolar Disorders
  14. Toll-like receptor 4 methylation grade is linked to depressive symptom severity
    Annica J. Rasmusson, Maike Gallwitz, Bardia Soltanabadi, Diana Maria Ciuculete, Jonas Mengel‐From, Kaare Christensen, Marianne Nygaard, Mette Soerensen, Adrian E. Desai Boström, Robert Fredriksson et al. · 2021 · Translational Psychiatry
  15. Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder
    Javier Garrosa, Yolanda Sánchez‐Carro, María Carmen Ovejero-Benito, Eric del Sastre, Antonio G. Garcı́a, Manuela G. López, Pilar López-García, María F. Cano‐Abad · 2021 · Neuroscience Letters
  16. The interaction of lipids and inflammatory markers predict negative symptom severity in patients with schizophrenia
    David R. Goldsmith, Nicholas Massa, Brian J. Miller, Andrew H. Miller, Erica Duncan · 2021 · Schizophrenia
  17. Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
    Lei Chen, Wenhui Zheng, Yang Du, Xuesong Li, Yun Yu, Hua Wang, Yong Cheng · 2021 · Frontiers in Medicine
  18. The lipid paradox in neuroprogressive disorders: Causes and consequences
    Morris, Gerwyn, Berk, Michael, Walder, Ken, O’Neil, Adrienne, Maes, Michael, Puri, Basant K. · 2021 · Neuroscience & Biobehavioral Reviews
  19. Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications
    Seong Hoon Jeong, Yong Sik Kim · 2021 · Clinical Psychopharmacology and Neuroscience
  20. Inflammation, cognitive dysfunction, and suicidal ideation among patients with major depression
    Mao‐Hsuan Huang, Mu‐Hong Chen, Ju-Wei Hsu, Kai‐Lin Huang, Shih‐Jen Tsai, Tung‐Ping Su, Ya‐Mei Bai · 2021 · CNS Spectrums
  21. Associations between heart rate variability, peripheral inflammatory markers and major depressive disorder
    Andreas Buchmann, Christopher Johannes Ritter, Sabrina Theresia Müller, Melanie Haynes, Carmen Ghisleni, Ruth Tuura, Gregor Hasler · 2022 · Journal of Affective Disorders
  22. The Impact of Hyper-Acute Inflammatory Response on Stress Adaptation and Psychological Symptoms of COVID-19 Patients
    I. Papava, L. Dehelean, R. Romosan, Mariana Bondrescu, Cristian Zoltan Dimeny, Eugenia Maria Domuta, F. Bratosin, Iulia Bogdan, M. Grigoraș, Codruta Victoria Tigmeanu et al. · 2022 · International Journal of Environmental Research and Public Health
  23. The Interrelation between Interleukin-2 and Schizophrenia
    Yu Huang, Xin Zhang, Na Zhou · 2022 · Brain Sciences
  24. Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression
    A.C. Rossetti, Maria Serena Paladini, César Augusto Brüning, Vittoria Spero, Maria Grazia Cattaneo, Giorgio Racagni, Mariusz Papp, Marco Andrea Riva, Raffaella Molteni · 2022 · International Journal of Molecular Sciences
  25. Gestational dexamethasone exposure impacts hippocampal excitatory synaptic transmission and learning and memory function with transgenerational effects
    Mingcui Luo, Yiwen Yi, Songqiang Huang, Shiyun Dai, Lulu Xie, Kexin Liu, Shuai Zhang, Tao Jiang, Tingting Wang, Baozhen Yao et al. · 2023 · Acta Pharmaceutica Sinica B
  26. Substance use disorders in schizophrenia: Prevalence, etiology, biomarkers, and treatment
    Heather Burrell Ward, Charles B. Nemeroff, Linda L. Carpenter, Adrienne L. Grzenda, William Maffitt McDonald, Carolyn I. Rodríguez, Nina Vanessa Kraguljac · 2023 · Personalized Medicine in Psychiatry
  27. Effects of inflammation, childhood adversity, and psychiatric symptoms on brain morphometrical phenotypes in bipolar II depression
    Yuan Cao, Huan Sun, Paulo L. Lizano, Gaoju Deng, Xiaoqin Zhou, Hongsheng Xie, Jingshi Mu, Xipeng Long, Hongqi Xiao, Shiyu Liu et al. · 2023 · Psychological Medicine
  28. Abnormal expression of miR-3653-3p, caspase 1, IL-1β in peripheral blood of schizophrenia
    Xinling Zhao, Yi-lin Liu, Qing Long, Yun-qiao Zhang, Xu You, Ze-yi Guo, Xiang Cao, Lei Yu, Fuyi Qin, Zhaowei Teng et al. · 2023 · BMC Psychiatry
  29. Cognitive and inflammatory heterogeneity in severe mental illness: Translating findings from blood to brain
    Linn Sofie Sæther, Attila Szabó, Ibrahim A. Akkouh, Beathe C. Haatveit, Christine Mohn, Anja Vaskinn, Pål Aukrust, Monica B E G Ormerod, Nils Eiel Steen, Ingrid S. Melle et al. · 2024 · Brain Behavior and Immunity
  30. Beyond pathogens: the intriguing genetic legacy of endogenous retroviruses in host physiology
    Amanda Lopes da Silva, Bruno Luiz Miranda Guedes, Samuel Nascimento Santos, Giovanna Francisco Correa, Ariane Nardy, Luiz Henrique da Silva Nali, André Luís Lacerda Bachi, Camila Malta Romano · 2024 · Frontiers in Cellular and Infection Microbiology
  31. Biomarkers for Psychosis: Are We There Yet? Umbrella Review of 1478 Biomarkers
    Paola Fuentes‐Claramonte, Andrés Estradé, Aleix Solanes, Valentina Ramella‐Cravaro, María Ángeles García‐León, Javier de Diego-Adeliño, Conrad Molins, Eric Fung, Marc Valentí, Gerard Anmella et al. · 2024 · Schizophrenia Bulletin Open
  32. Effects of 6-week olanzapine treatment on serum IL-2, IL-4, IL-8, IL-10, and TNF-α levels in drug-naive individuals with first-episode schizophrenia
    Xiaofeng Zhao, Wenli Zhu, Yangying Bu, Junwei Li, Yihui Hao, Yuxiao Bi · 2024 · BMC Psychiatry
  33. Immunological drivers and potential novel drug targets for major psychiatric, neurodevelopmental, and neurodegenerative conditions
    Christina Dardani, Jamie W. Robinson, Hannah J Jones, Dheeraj Rai, Evie Stergiakouli, Jakob Grove, Renee M. Gardner, Andrew Mark McIntosh, Alexandra Havdahl, Gibran Hemani et al. · 2025 · Molecular Psychiatry
  34. Immunity and psychiatric disorders: variabilities of immunity biomarkers are they specific?
    Thomas Dubois, Christine Reynaert, Denis Jacques, Brice Lepièce, Pierre Patigny, Nicolas Zdanowicz · 2018 · PubMed
  35. Effect of risperidone treatment on insulin-like growth factor-1 and interleukin-17 in drug naïve first-episode schizophrenia
    Dachun Chen, Hongna Li, Qing Zhao, Jiaqi Song, Lin Chen, Jianjin Yu · 2021 · Psychiatry Research
  36. Tetracyclines, a promise for neuropsychiatric disorders: from adjunctive therapy to the discovery of new targets for rational drug design in psychiatry
    Adriano José Maia Chaves Filho, Melina Mottin, Michele Verde-Ramo Soares, Paloma Marinho Jucá, Carolina Horta Andrade, Danielle S. Macêdo · 2021 · Behavioural Pharmacology
  37. Prefrontal dopamine D1 receptor manipulation influences anxiety behavior and induces neuroinflammation within the hippocampus
    Dominik K. E. Beyer, Annika Mattukat, Nadja Freund · 2021 · International Journal of Bipolar Disorders
  38. Low-dose candesartan prevents schizophrenia-like behavioral alterations in a neurodevelopmental two-hit model of schizophrenia
    Germana Silva Vasconcelos, Manuel Alves Santos Júnior, Aline Santos Monte, Francisco Eliclécio Rodrigues da Silva, Camila Nayane de Carvalho Lima, Abelardo Barbosa Moreira Lima Neto, Ingridy da Silva Medeiros, Antônio Lúcio Teixeira, David Freitas de Lucena, Silvânia Maria Mendes Vasconcelos et al. · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  39. Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study
    Naomichi Okamoto, Tomoya Natsuyama, Ryohei Igata, Yuki Konishi, Hirofumi Tesen, Atsuko Ikenouchi, Reiji Yoshimura · 2021 · Frontiers in Psychiatry
  40. Volatile organic compounds from exhaled breath in schizophrenia
    Carina Jiang, Henrik Dobrowolny, Dorothee Maria Gescher, Gabriela Meyer-Lotz, Johann Steiner, Christoph Hoeschen, Thomas Frodl · 2022 · The World Journal of Biological Psychiatry
  41. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study
    Kerstin Langbein, Ulrike Schmidt, Stephan Schack, Natalie Joan Biesel, Maria Rudzok, G. Paul Amminger, Maximus Berger, Heinrich Sauer, Stefan Smesny · 2017 · Schizophrenia Research
  42. The Emerging Neurobiology of Bipolar Disorder
    Paul J. Harrison, John Richard Geddes, Elizabeth M. Tunbridge · 2019 · FOCUS The Journal of Lifelong Learning in Psychiatry
  43. Altered Levels of Salivary Cytokines in Patients with Major Depressive Disorder
    Yui, Sumie, Sasayama, Daimei, Yamaguchi, Masaki, Washizuka, Shinsuke · 2022 · Clinical Neurology and Neurosurgery
  44. Childhood maltreatment correlates with higher concentration of transforming growth factor beta (TGF-β) in adult patients with major depressive disorder
    Jovanovic, Ana Munjiza, Mitkovic-Voncina, Marija, Kostic, Milutin, Jeremic, Marija, Todorovic, Jovana, Popadic, Dusan, Tosevski, Dusica Lecic, Markovic, Ivanka · 2021 · Psychiatry Research
  45. Ginsenoside Rd alleviates LPS-induced neuroinflammation and depressive-like behaviors via regulating TLR4-PI3K-NF-κB-JMJD3 signaling
    Hongyu Chen, Jingjing Piao, Zihui Geng, Xu Han, Runxin Li, Ranji Cui, Bingjin Li · 2025 · International Immunopharmacology
  46. Mood disorders in pregnant women and future cardiovascular risk
    Nathalie Auger, Brian James Potter, Jessica Healy‐Profitós, Siyi He, Mireille E. Schnitzer, Gilles Paradis · 2020 · Journal of Affective Disorders
  47. The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis
    Kyle Jon Burghardt, Wasym Mando, Berhane Seyoum, Zhengping Yi, Paul Ryen Burghardt · 2022 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  48. Is it possible to stage schizophrenia? A systematic review
    Clara Martínez-Cao, Lorena de la Fuente-Tomás, Ainoa García-Fernández, Leticia González-Blanco, Pilar Alejandra Sáiz, María Paz García‐Portilla, Julio Bobes · 2022 · Translational Psychiatry
  49. Suppressors of Cytokine Signaling Are Decreased in Major Depressive Disorder Patients
    Nobuyuki Kobayashi, Shunichiro Shinagawa, Tomoyuki Nagata, Masahiro Shigeta, Kazuhiro Kondo · 2022 · Journal of Personalized Medicine
  50. Lithium exposure and chronic inflammation with activated macrophages and monocytes associated with atherosclerosis in bipolar disorder
    Shang‐Ying Tsai, Chian‐Jue Kuo, Martha Sajatovic, Yu‐Jui Huang, Pao‐Huan Chen, Kuo‐Hsuan Chung · 2022 · Journal of Affective Disorders
  51. Cerebrospinal fluid proteomic study of two bipolar disorder cohorts
    Anniella Isgren, Andreas Göteson, Jessica Holmén‐Larsson, Aurimantas Pelanis, Carl M. Sellgren, Erik Joas, Timea Sparding, Henrik Zetterberg, Erik Smedler, Joel Jakobsson et al. · 2022 · Molecular Psychiatry
  52. The Association of Biochemical and Genetic Biomarkers in VEGF Pathway with Depression
    Fernanda Daniela Dornelas Nunes, Letícia Perticarrara Ferezin, Sherliane Carla Pereira, Fernanda Viana Fígaro-Drumond, Lucas Cezar Pinheiro, Itiana Castro Menezes, Cristiane von Werne Baes, Fernanda Borchers Coeli‐Lacchini, José Eduardo Tanus-Santos, Mário F. Juruena et al. · 2022 · Pharmaceutics
  53. C-Reactive Protein (CRP): A Potent Inflammation Biomarker in Psychiatric Disorders
    Laura Orsolini, Simone Pompili, Umberto Volpe · 2023 · Advances in experimental medicine and biology
  54. Effects of a six-month yoga intervention on the immune-inflammatory pathway in antipsychotic-stabilized schizophrenia patients: A randomized controlled trial
    Thrinath Mullapudi, Monojit Debnath, Ramajayam Govindaraj, Praveen Raj, Moinak Banerjee, Shivarama S. Varambally · 2023 · Asian Journal of Psychiatry
  55. Counting the Toll of Inflammation on Schizophrenia—A Potential Role for Toll-like Receptors
    Saahithh Redddi Patlola, Gary J Donohoe, Declan Patrick McKernan · 2023 · Biomolecules
  56. Immune-Inflammatory Response And Compensatory Immune-Regulatory Reflex Systems And White Matter Integrity in Schizophrenia
    Mengzhuang Gou, Wenjin Chen, Yanli Li, Song Chen, Wei Feng, Shujuan Pan, Xingguang Luο, Shuping Tan, Baopeng Tian, Wei Li et al. · 2023 · Schizophrenia Bulletin
  57. Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trial
    Sarah E. Herniman, Stephen James Wood, Golam Mohammed Khandaker, Paola Dazzan, Carmine Maria Pariante, Nicholas M. Barnes, Carl R. Krynicki, Naghmeh Nikkheslat, Rachel C. Vincent, Alexander Roberts et al. · 2023 · Translational Psychiatry
  58. Identification of immune-related biomarkers in peripheral blood of schizophrenia using bioinformatic methods and machine learning algorithms
    Xiaoli Zhu, C. Wang, Jianfeng Yu, Jianjun Weng, Bing Han, Yanqing Liu, Xiaowei Tang, Bo Pan · 2023 · Frontiers in Cellular Neuroscience
  59. Multivariate analyses of immune markers reveal increases in plasma EN-RAGE in first-episode psychosis patients
    Laura Korhonen, Elisabeth R. Paul, Karin Wåhlén, Liina Haring, Eero Vasar, Antti I. Vaheri, Dan Lindholm · 2023 · Translational Psychiatry
  60. Altered serum TNF-α and MCP-4 levels are associated with the pathophysiology of major depressive disorder: A case-control study results
    Jannatul Nayem, Rapty Sarker, A. S. M. Roknuzzaman, MMA Shalahuddin Qusar, Sheikh Zahir Raihan, Md. Rabiul Islam, Zobaer Al Mahmud · 2023 · PLoS ONE
  61. Associations between insomnia symptoms and inflammatory cytokines in adolescents with first-episode and recurrent major depressive disorder
    Lewei Liu, Xiaoxue Yang, Cheng Zhi Yang, Yinghan Tian, Wenzheng Li, Lei Xia, Huanzhong Liu · 2024 · Journal of Affective Disorders
  62. Gut Microbiota Dysbiosis and Inflammation Dysfunction in Late-Life Depression: An Observational Cross-Sectional Analysis
    Yan Chen, Dansheng Le, Jiaxi Xu, Piaopiao Jin, Yuhan Zhang, Zhengluan Liao · 2024 · Neuropsychiatric Disease and Treatment
  63. Genetic correlation and causal associations between psychiatric disorders and lung cancer risk
    Jiajun Shi, Wanqing Wen, Jirong Long, Eric R. Gamazon, Ran Tao, Qiuyin Cai · 2024 · Journal of Affective Disorders
  64. Immune dysregulation in psychiatric disorders with and without exposure to childhood maltreatment: A transdiagnostic stratified meta-analysis
    Minne Van Den Noortgate, Manuel Morrens, Marianne Foiselle, Livia De Picker · 2025 · Brain Behavior and Immunity
  65. Tumor necrosis factor‐alpha −1031T/C polymorphism is associated with cognitive deficits in chronic schizophrenia patients versus healthy controls
    Mei Hong Xiu, Lijuan Man, Dong Wang, Xiangdong Du, Guangzhou Yin, Yingyang Zhang, Yun Tan, Nan Chen, Song Chen, Antônio Lúcio Teixeira et al. · 2018 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  66. Ω-3 fatty acids-supplementary in gestation alleviates neuroinflammation and modulates neurochemistry in rats
    Mimi Tang, Ruili Dang, Shao Liu, Mengqi Zhang, Yi Zheng, Rui Yang, Tao Yin · 2018 · Lipids in Health and Disease
  67. Agmatine as a potential therapeutic intervention in bipolar depression: the preclinical landscape
    Devon Watts, Bianca Pfaffenseller, Bianca Wollenhaupt-Aguiar, Luíza Paul Géa, Taiane de Azevedo Cardoso, Flávio Pereira Kapczinski · 2019 · Expert Opinion on Therapeutic Targets
  68. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
    Sue Cotton, M. Berk, Amity Watson, Stephen James Wood, Kelly Allott, Cali Bartholomeusz, Chiara C. Bortolasci, Ken R. Walder, Brian N. O'Donoghue, Olivia May Dean et al. · 2019 · Trials
  69. Possible utilization of salivary IFN‐γ/IL‐4 ratio as a marker of chronic stress in healthy individuals
    Yuika Takemori, Daimei Sasayama, Yukiyo Toida, Minori Kotagiri, Nobuhiro Sugiyama, Masaki Yamaguchi, Shinsuke Washizuka, Hideo Honda · 2021 · Neuropsychopharmacology Reports
  70. Associations of Genetic Polymorphisms and Neuroimmune Markers With Some Parameters of Frontal Lobe Dysfunction in Schizophrenia
    Anna Y. Morozova, Yana Zorkina, К. А. Павлов, Olga Pavlova, Olga V. Abramova, Valeriya M. Ushakova, Alexander V. Mudrak, Svetlana A. Zozulya, I. N. Otman, Z. V. Sarmanova et al. · 2021 · Frontiers in Psychiatry
  71. Impact of Fluoxetine on Behavioral Invigoration of Appetitive and Aversively Motivated Responses: Interaction With Dopamine Depletion
    Carla Carratalá‐Ros, Laura López‐Cruz, Andrea Martínez-Verdú, Régulo Olivares-García, John D. Salamone, Mercè Correa · 2021 · Frontiers in Behavioral Neuroscience
  72. Expression of immune-related proteins and their association with neuropeptides in adolescent patients with anorexia nervosa
    Marta Tyszkiewicz‐Nwafor, Katarzyna Jowik, Elżbieta Paszyńska, Agata Dutkiewicz, Agnieszka Słopień, Monika Dmitrzak‐Węglarz · 2021 · Neuropeptides
  73. Brain temperature as an indicator of neuroinflammation induced by typhoid vaccine: Assessment using whole-brain magnetic resonance spectroscopy in a randomised crossover study
    Julia R. Plank, Catherine Morgan, Frederick Sundram, Lindsay Dudley Plank, Nicholas R. Hoeh, Sinyeob Ahn, Suresh D Muthukumaraswamy, Joanne C. Lin · 2022 · NeuroImage Clinical
  74. Increased immuno-inflammatory mediators in women with post-traumatic stress disorder after sexual assault: 1-Year follow-up
    Ana Teresa D'Elia, Mário F. Juruena, Bruno Messina Coimbra, Marcelo F. Mello, Andréa F. Mello · 2022 · Journal of Psychiatric Research
  75. Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia
    Murielle Brum, Matthias Nieberler, Christopher Kehrwald, Katrin Knopf, Nathalie Brunkhorst-Kanaan, Semra Etyemez, Kelly Ann Allers, Robert A. Bittner, David Anthony Slattery, Rhiannon Victoria McNeill et al. · 2023 · The World Journal of Biological Psychiatry
  76. Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and C-reactive protein levels and metabolic status in patients with a bipolar disorder
    Sanchez-Autet, Monica, Arranz, Belén, Sierra, Pilar, Safont, Gemma, Garcia-Blanco, Ana, de la Fuente, Lorena, Garriga, Marina, Marín, Lorena, García-Portilla, Maria Paz · 2022 · The World Journal of Biological Psychiatry
  77. Disease severity across psychiatric disorders is linked to pro-inflammatory cytokines
    Pierre Solomon, Monika Budde, Mojtaba Oraki Kohshour, Kristina Adorjan, Maria Heilbronner, Alba Navarro‐Flores, Sergi Papiol, Daniela Reich‐Erkelenz, Eva Christina Schulte, Fanny Senner et al. · 2025 · Brain Behavior and Immunity
  78. Association between TNF-alpha polymorphism and the age of first suicide attempt in chronic patients with schizophrenia
    Xiaoe Lang, Tammy H. Trihn, Hanjing Emily Wu, Yongsheng Tong, Meihong Xiu, Xiangyang Zhang · 2020 · Aging
  79. Common and disorder-specific upregulation of the inflammatory markers TRAIL and CCL20 in depression and schizophrenia
    Federica Klaus, Karoline Guetter, Rebecca Schlegel, Tobias R. Spiller, Erich Seifritz, Flurin Cathomas, Stefan Kaiser · 2021 · Scientific Reports
  80. Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats
    Rachel Shvartsur, Galila Agam, Sarit Uzzan, Abed N. Azab · 2022 · Pharmaceutics
  81. The emerging role of long non-coding RNAs in schizophrenia
    Guangxian Wu, Xinzhe Du, Zexuan Li, Yanhong Du, Jinzhi Lv, Xinrong Li, Yong Xu, Sha Liu · 2022 · Frontiers in Psychiatry
  82. Diagnosis of Schizophrenia Based on the Data of Various Modalities: Biomarkers and Machine Learning Techniques (Review)
    Maxim Sharaev, И К Малашенкова, А. В. Масленникова, Natalia V. Zakharova, A.V. Bernstein, Evgeny Vladimirovich Burnaev, Galina Mamedova, Sergey Krynskiy, Daniil Ogurtsov, E.A. Kondrateva et al. · 2022 · Современные технологии в медицине
  83. Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis
    Clàudia Aymerich, Borja Pedruzo, Malein Pacho, María Laborda, Jon Herrero, Toby Pillinger, Robert Ali McCutcheon, Daniel Alonso Alconada, Marta Bordenave, Maria Martínez-Querol et al. · 2023 · Psychoneuroendocrinology
  84. SIRT1/PARP-1/NLRP3 cascade as a potential target for niacin neuroprotective effect in lipopolysaccharide-induced depressive-like behavior in mice
    Nora O. Abdel Rasheed, Nesma A. Shiha, Sarah S. Mohamed, Weam W. Ibrahim · 2023 · International Immunopharmacology
  85. Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis
    Takuya Miyano, Tsuyoshi Mikkaichi, Kouichi Nakamura, Yasushi Yoshigae, Kelly Abernathy, Yuji Ogura, Naoki Kiyosawa · 2024 · International Journal of Molecular Sciences
  86. Cyclooxygenase-2 inhibitors alleviated depressive and anxious-like behaviors in mice exposed to lipopolysaccharide: Involvement of oxidative stress and neuroinflammation
    Daniel Moreira Alves da Silva, Iardja Stéfane Lopes, João Victor Souza Oliveira, Manuel Alves Santos Júnior, Manoela de Oliveira Rebouças, José Tiago Valentim, Larice de Carvalho Vale, Victor Celso Cavalcanti Capibaribe, Michele Albuquerque Jales de Carvalho, Pedro Éverson Alexandre de Aquino et al. · 2024 · Pharmacology Biochemistry and Behavior
  87. Microbiota-gut-brain axis in perioperative neurocognitive and depressive disorders: Pathogenesis to treatment
    Mengxin Que, Shiyong Li, Xia Qian, Xing Li, Xiaoxiao Luo, Gaofeng Zhan, Ailin Luo · 2024 · Neurobiology of Disease
  88. An intricate relationship between circadian rhythm dysfunction and psychiatric diseases
    Saptadip Samanta, Debasis Bagchi · 2024 · Exploration of neuroscience
  89. Network analysis of depressive symptoms and C-reactive protein levels in major depressive disorder
    Dongfang Wang, Jianchang Xu, Nana Liang, Zhenpeng Xue, Xiujuan Yang, Jianping Lu, Yuejiao Ma · 2024 · Journal of Affective Disorders
  90. Psychedelics and schizophrenia: a double-edged sword
    Jacopo Sapienza, Francesca Martini, Stefano Comai, Roberto Cavallaro, Marco Spangaro, Danilo De Gregorio, Marta Bosia · 2024 · Molecular Psychiatry
  91. Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in major depressive disorder: Protocol of the INSTA-MD double-blind placebo-controlled randomised clinical trial
    Céline Wessa, J. Janssens, Violette Coppens, Kawtar El Abdellati, Elfi Vergaelen, Seline van den Ameele, Chris Baeken, Dieter Zeeuws, Yuri Milaneschi, Femke Lamers et al. · 2024 · Brain Behavior & Immunity - Health
  92. Increased peripheral levels of TARC/CCL17 in first episode psychosis patients
    Anna Malmqvist, Lilly Schwieler, Funda Orhan, Helena Fatouros‐Bergman, Markus Bauer, Lena Flyckt, Simon Červenka, Göran Engberg, Fredrik Piehl, Sophie Erhardt · 2019 · Schizophrenia Research
  93. Anti-inflammatory Effect of Ghrelin in Lymphoblastoid Cell Lines From Children With Autism Spectrum Disorder
    Yasunori Yamashita, Manabu Makinodan, Michihiro Toritsuka, Takahira Yamauchi, Daisuke Ikawa, Sohei Kimoto, Takashi Komori, Ryohei Takada, Yoshinori Kayashima, Kaori Hamano-Iwasa et al. · 2019 · Frontiers in Psychiatry
  94. Is there a role for antibodies targeting muscarinic acetylcholine receptors in the pathogenesis of schizophrenia?
    Alexander E. Ryan, Bryan J. Mowry, James P. Kesby, James G. Scott, Judith M. Greer · 2019 · Australian & New Zealand Journal of Psychiatry
  95. Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases
    Nuria García‐Marchena, Rosa María Maza-Quiroga, Antonia Serrano, Vicente Barrios, Nerea Requena-Ocaña, Juan Suárez, Julie Ann Chowen, Jesús Argente, Gabriel Rubio, Marta Torrens et al. · 2020 · Journal of Psychopharmacology
  96. The association between serum levels of TNF-α and IL-6 in schizophrenic patients and their metabolic status – A case control study
    Jaśmina Arabska, Dominik Strzelecki, Elżbieta Kozłowska, Ewa Brzezińska‐Błaszczyk, Adam Wysokiński · 2020 · Journal of Neuroimmunology
  97. The independent and combined effects of cannabis use and systemic inflammation during the early stages of psychosis: exploring the two-hit hypothesis
    Fabiana Maria das Graças Corsi Zuelli, Leonardo André da Costa Marques, Daiane Leite da Roza, Camila Marcelino Loureiro, Rosana Shuhama, Marta Di Forti, Paulo Rossi Menezes, Paulo Louzada‐Júnior, Cristina Marta Del‐Ben · 2021 · Psychological Medicine
  98. ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state
    Wookbong Kwon, Seong‐Kyoon Choi, Dae-Hwan Kim, Hyeon‐Gyeom Kim, Jin‐Kyu Park, Jee Eun Han, Gil‐Jae Cho, Sungho Yun, Wookyung Yu, Se‐Hyeon Han et al. · 2021 · Journal of Experimental & Clinical Cancer Research
  99. Pentoxifylline for treatment of major depression after percutaneous coronary intervention or coronary artery bypass grafting: A randomized, double-blind, placebo-controlled trial
    Seyyede-Ozra Yasrebi, Sara Momtazmanesh, Hossein Sanjari Moghaddam, Nazila Shahmansouri, Maryam Mehrpooya, Mohammad Arbabi, Fatemeh Ghazizadeh‐Hashemi, Shahin Akhondzadeh · 2021 · Journal of Psychosomatic Research
  100. Association of serum interleukin-6 and C-reactive protein with depressive and adjustment disorders in COVID-19 inpatients
    María Iglesias-González, Marc Boigués, David Sanagustín, Maria Giralt‐López, Jorge Cuevas‐Esteban, Eva María Martínez-Cáceres, Crisanto Díez · 2021 · Brain Behavior & Immunity - Health